Cryo-Save Group N.V. (CRYO) 0.2280 $CRYO
American CryoStem Appoints Nobel Prize Nominee and One of the Leading Stem Cell Experts Vincent C. Giampapa, M.D. to Its Medical and Scientific Advisory Board
Marketwired - Thu Apr 14, 7:01AM CDT
American CryoStem Corporation (OTC PINK: CRYO), a leading developer and marketer of patented adipose tissue-based cellular technologies for the regenerative and personalized medicine industries with laboratories in New Jersey, and licensed labs in Tokyo, Hong Kong and Shenzhen, China, today announced it has appointed Vincent C. Giampapa, M.D., F.A.C.S. to the Company's Medical and Scientific Advisory Board. In this capacity, he will have an active role assisting the Company with the development of its "From laboratory to clinic/physician's office" services and applications platform.
AGN: 247.21 (+0.25), SNY: 41.16 (+0.02)
American CryoStem Corporation Retains Investor Relations Partners as Investor Relations Counsel
Marketwired - Fri Apr 01, 7:00AM CDT
American CryoStem Corporation (OTC PINK: CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that it has retained Investor Relations Partners (IRP) to expand the Company's strategic investor relations program.
TARO: 148.90 (+1.34), HOT: 74.94 (-0.06)
American Cryostem Welcomes Dr. KiBum Lee To Medical & Scientific Advisory Board
ACCESSWIRE - Wed Jun 03, 7:57AM CDT
EATONTOWN, NJ / ACCESSWIRE / June 3, 2015 / American CryoStem Corporation (PINKSHEETS: CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced the addition of Dr. KiBum Lee to the Medical & Scientific Advisory Board.
Radiant Pain Relief Centres Announces Board of Directors
BusinessWire - Tue May 05, 1:39PM CDT
Radiant Pain Relief Centres, which opened a pilot clinic in February 2014, announced that it established a board of directors this month as it moves forward in its plan to expand to more than 100 clinics in North America over the next five years. Board appointments include chairman Edward Brennan, Ph.D., a technology and healthcare entrepreneur; Thomas Rota, a Silicon Valley veteran; and P. Brendon Lundberg, president and CEO of Radiant. The two outside appointments were selected based on their experience with start-up companies, mergers and acquisitions, and corporate financing.
KRC: 62.49 (-0.85)
American Cryostem Announces Acquisition of Biolife Cell Bank
ACCESSWIRE - Mon Apr 20, 7:30AM CDT
EATONTOWN, NJ / ACCESSWIRE / April 20, 2015 / American CryoStem Corporation (PINKSHEETS: CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced the acquisition of Biolife Cell Bank's (Biolife) adipose tissue and adipose derived stem cell banking services assets.
American CryoStem Appoints Nobel Prize Nominee and One of the Leading Stem Cell Experts Vincent C. Giampapa, M.D. to Its Medical and Scientific Advisory Board
Marketwired - Thu Apr 14, 7:01AM CDT
American CryoStem Corporation (OTC PINK: CRYO), a leading developer and marketer of patented adipose tissue-based cellular technologies for the regenerative and personalized medicine industries with laboratories in New Jersey, and licensed labs in Tokyo, Hong Kong and Shenzhen, China, today announced it has appointed Vincent C. Giampapa, M.D., F.A.C.S. to the Company's Medical and Scientific Advisory Board. In this capacity, he will have an active role assisting the Company with the development of its "From laboratory to clinic/physician's office" services and applications platform.
AGN: 247.21 (+0.25), SNY: 41.16 (+0.02)
American CryoStem Corporation Retains Investor Relations Partners as Investor Relations Counsel
Marketwired - Fri Apr 01, 7:00AM CDT
American CryoStem Corporation (OTC PINK: CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that it has retained Investor Relations Partners (IRP) to expand the Company's strategic investor relations program.
TARO: 148.90 (+1.34), HOT: 74.94 (-0.06)
American Cryostem Welcomes Dr. KiBum Lee To Medical & Scientific Advisory Board
ACCESSWIRE - Wed Jun 03, 7:57AM CDT
EATONTOWN, NJ / ACCESSWIRE / June 3, 2015 / American CryoStem Corporation (PINKSHEETS: CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced the addition of Dr. KiBum Lee to the Medical & Scientific Advisory Board.
Radiant Pain Relief Centres Announces Board of Directors
BusinessWire - Tue May 05, 1:39PM CDT
Radiant Pain Relief Centres, which opened a pilot clinic in February 2014, announced that it established a board of directors this month as it moves forward in its plan to expand to more than 100 clinics in North America over the next five years. Board appointments include chairman Edward Brennan, Ph.D., a technology and healthcare entrepreneur; Thomas Rota, a Silicon Valley veteran; and P. Brendon Lundberg, president and CEO of Radiant. The two outside appointments were selected based on their experience with start-up companies, mergers and acquisitions, and corporate financing.
KRC: 62.49 (-0.85)
American Cryostem Announces Acquisition of Biolife Cell Bank
ACCESSWIRE - Mon Apr 20, 7:30AM CDT
EATONTOWN, NJ / ACCESSWIRE / April 20, 2015 / American CryoStem Corporation (PINKSHEETS: CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced the acquisition of Biolife Cell Bank's (Biolife) adipose tissue and adipose derived stem cell banking services assets.
